You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 20, 2025

~ Buy the STENDRA (avanafil) Drug Profile, 2024 PDF Report in the Report Store ~

Drug Price Trends for STENDRA


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for STENDRA

Best Wholesale Price for STENDRA

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)UnitDatesPrice Type
STENDRA 100MG TAB Metuchen Pharmaceuticals, LLC 72384-0752-30 30 1945.46 64.84867 EACH 2022-06-01 - 2025-02-14 FSS
STENDRA 200MG TAB Metuchen Pharmaceuticals, LLC 76299-0322-85 30 1945.46 64.84867 EACH 2022-01-01 - 2025-02-14 FSS
STENDRA 50MG TAB Metuchen Pharmaceuticals, LLC 72384-0751-30 30 1945.46 64.84867 EACH 2022-06-01 - 2025-02-14 FSS
STENDRA 50MG TAB Metuchen Pharmaceuticals, LLC 76299-0320-85 30 1462.16 48.73867 EACH 2022-01-01 - 2025-02-14 Big4
STENDRA 200MG TAB Metuchen Pharmaceuticals, LLC 72384-0753-30 30 1459.58 48.65267 EACH 2024-01-01 - 2025-02-14 Big4
STENDRA 200MG TAB Metuchen Pharmaceuticals, LLC 72384-0753-30 30 1448.06 48.26867 EACH 2021-01-01 - 2025-02-14 Big4
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Unit>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 1 to 6 of 6 entries

Market Analysis and Price Projections for Stendra (Avanafil)

Market Overview

The global erectile dysfunction (ED) drugs market is poised for significant growth, and Stendra (Avanafil) is one of the key players in this segment. Here’s a detailed analysis of the market and price projections for Stendra.

Market Size and Growth

The global ED drugs market is expected to expand substantially over the next few years. By 2030, the market is projected to reach USD 4.90 billion, growing at a CAGR of 9.13% from 2025 to 2030[4].

Stendra's Market Position

Stendra, also known as Avanafil, is a phosphodiesterase type 5 (PDE5) inhibitor used to treat erectile dysfunction. It has shown promising results in clinical trials, particularly in a phase 3 clinical trial conducted by Sichuan Haisco Pharmaceutical Co., Ltd. in mainland China. The trial demonstrated improvement in ED patients after administration of two doses of Stendra 100 mg and 200 mg, which may strengthen its position in the market[4].

Revenue Estimates

While specific revenue estimates for Stendra alone are not provided in the sources, it is part of the broader ED drugs market that includes other prominent drugs like Viagra, Cialis, and Levitra. Here is a general breakdown of the market:

  • Viagra (Sildenafil Citrate) holds a significant market share, with a revenue share of about 58% in the ED drugs market[3].
  • Cialis (Tadalafil) and other drugs like Levitra/Staxyn and Zydena also contribute to the market, but Stendra is expected to gain traction due to its clinical effectiveness.

Distribution Channels

The distribution of Stendra, like other ED drugs, is primarily through:

  • Retail Pharmacies: Holding the largest revenue share at about 46%[3].
  • Hospital Pharmacies: With a significant market share of around 35%[3].
  • Online Pharmacies: Also playing a crucial role in the distribution.

Regional Analysis

The market for ED drugs, including Stendra, is geographically diverse:

  • North America: Held the highest revenue share in 2022, with 51.7% of the market[3].
  • Asia Pacific: Also a significant region, with a revenue share of 26.3% in 2022[3].

Price Projections

The pricing of Stendra can vary based on several factors, including location, distribution channel, and availability of generic versions.

Current Pricing

  • Stendra: Typically costs between USD 70 to 75 per pill, similar to other branded ED drugs[3].

Generic Versions

  • Generic Sildenafil: Starts from USD 8.5 or less per pill, indicating a significant price difference between branded and generic versions[3].

Future Pricing Trends

Given the competitive nature of the ED drugs market and the increasing demand, prices may stabilize or see moderate increases. However, the lack of specific price projections for Stendra in the sources suggests that its pricing will likely follow the broader market trends.

Market Drivers and Restraints

Drivers

  • Clinical Effectiveness: Proven efficacy in clinical trials, such as the phase 3 trial in China, supports the growth of Stendra in the market[4].
  • Increasing Awareness: Although there is still a lack of awareness about ED treatments, efforts to educate the public could drive demand for Stendra and other ED drugs.

Restraints

  • Social Stigma: Shame and social stigma associated with ED treatment can restrain market growth[4].
  • Lack of Discretion: Limited discretion in purchasing ED drugs can also hinder the market[4].

Competitive Landscape

The ED drugs market is highly competitive, with several key players:

  • Viagra (Sildenafil Citrate): Dominates the market with a significant revenue share.
  • Cialis (Tadalafil): Another major player with a strong market presence.
  • Stendra (Avanafil): Positioned to gain market share due to its clinical effectiveness and relatively fast onset of action.

Key Takeaways

  • Market Growth: The ED drugs market, including Stendra, is expected to grow significantly, driven by increasing demand and clinical effectiveness.
  • Pricing: Stendra's pricing is currently in line with other branded ED drugs, but generic versions offer a cheaper alternative.
  • Distribution: Retail and hospital pharmacies are the primary distribution channels.
  • Regional Presence: North America and Asia Pacific are key regions for the ED drugs market.

FAQs

What is the expected growth rate of the ED drugs market?

The ED drugs market is expected to grow at a CAGR of 6.8% to 9.13% from 2023 to 2030, depending on the forecast period and source[3][4].

Which drug holds the largest market share in the ED drugs market?

Viagra (Sildenafil Citrate) holds the largest market share, with approximately 58% of the revenue[3].

What are the primary distribution channels for Stendra and other ED drugs?

Retail pharmacies and hospital pharmacies are the primary distribution channels, with online pharmacies also playing a significant role[3].

How does the pricing of Stendra compare to generic versions?

Stendra typically costs between USD 70 to 75 per pill, while generic sildenafil can start from USD 8.5 or less per pill[3].

What are the main drivers and restraints for the Stendra market?

Drivers include clinical effectiveness and increasing awareness, while restraints include social stigma and lack of discretion in purchasing ED drugs[4].

Which regions are most significant for the ED drugs market?

North America and Asia Pacific are the most significant regions for the ED drugs market, including Stendra[3].

Sources

  1. Mordor Intelligence: Erectile Dysfunction Drugs Market Size & Share Analysis
  2. Heraeus Precious Metals: Precious metal forecast for 2025
  3. Market.us: Erectile Dysfunction Drugs Market Size | CAGR of 6.8%
  4. ResearchAndMarkets: Erectile Dysfunction Drugs Market Size, Share & Trends Analysis

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.